1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

Women’s Health - Assessing the Need for a Targeted and Specialized Approach

  • January 2015
  • 69 pages
  • CBR Pharma Insights
Report ID: 2787562

Summary

Table of Contents

Search Inside

Women’s Health - Assessing the Need for a Targeted and Specialized Approach

Summary

Many of the diseases and conditions that affect mainly women are interlinked with similar root causes; however, placing all of the pieces of the puzzle together to ensure a cohesive management strategy remains a challenge.

Women’s Health is a collection of multi-factorial conditions and diseases that solely affect or are more prevalent in females. Many can have a serious impact on women’s overall long-term health and quality of life. There are a number of causes of Women’s Health diseases, ranging from hormonal fluctuations associated with specific points in a woman’s life through to psychological issues underpinning certain lifestyle disorders. As these causes and the courses and consequences of these diseases become better understood, the importance of targeted, specific treatment is increasingly being recognized, with some female-specific interventions now being investigated. In addition, it is becoming increasingly crucial to understand and act on the interaction between different diseases that primarily affect women, in order to ensure the most effective treatment approaches.

Female cancers, particularly breast and cervical, have led the way in preventive and therapeutic approaches, creating new paths for the management of other cancers and rendering some previously highly terminal cancers manageable diseases. The advent of personalized therapy for HER2-positive breast cancer was enabled through the identification of the HER2 gene and development of targeted drugs, such as Herceptin (trastuzumab) and Tyverb (lapatinib), and the prevention of cancer through vaccination has become the norm for cervical cancer. However, the same cannot be said for other female cancers, where, in spite of identification of gene mutations, targeted therapy is still in its infancy.

Despite significant advances in Women’s Health, there are still a number of unmet needs, particularly for therapies that address the fundamental causes of many conditions that are specific to or more prevalent in women. The fact that women are living longer means that they are encountering a wider range of health issues. It also means that there are higher expectations in therapies and that factors such as quality of life are playing an increasingly important role. As the Women’s Health environment evolves and expectations in treatment increase, easier and more straightforward therapies will be needed, and there is a particular need for drugs that either address several aspects of Women’s Health or work concomitantly with others to do so. Furthermore, it is recognized that many of the different conditions that affect women are interlinked and have common root causes; however, placing all of the pieces of the puzzle together to ensure a cohesive management strategy remains a challenge. The specialists who can do this are likely to be the main points of care for Women’s Health.

Scope

The report provides an overview of issues and trends in Women’s Health, including analysis of the current market landscape and key issues driving overall treatment decisions. In addition, the report offers a view of how Women’s Health is likely to evolve, including treatment practices and new approaches in the pipeline.The report covers and includes -
- A brief introduction to Women’s Health and the key diseases and conditions that affect women, including female cancers, psychological issues, sexual dysfunction and cardiovascular disease
- Detailed analysis of why certain diseases affect women in different ways or in larger numbers, the impact that this has on overall health and quality of life, and current approaches to managing these conditions
- Analysis of the pipeline for specific women’s diseases including an overview of how personalized medicine is likely to change how certain conditions are treated
- An overview of how Women’s Health will be managed in the future, specifically looking at how specialists will adopt a multi-disciplinary approach to ensure the holistic treatment of the “whole woman”

Reasons to buy

Primarily, the report will allow clients to gain a strong understanding of the current landscape in Women’s Health, helping them to identify and clarify market opportunities and the competitive environment. It will also allow clients to -
- Understand why specific diseases and conditions present differently in women and the implications for treatment and management
- Examine developments in Women’s Health and how this has impacted on the incidence and prevalence of certain diseases, along with the overall prognosis and outcomes for women with particular conditions
- Assess where the key unmet needs in Women’s Health exist and how these opportunities can be harnessed in future drug development
- Understand the different issues and challenges facing companies when developing therapies for Women’s Health conditions and how these can most effectively be addressed to ensure future success

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast – 2025

  • $ 5750
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s “Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Interstitial Cystitis ...

Global Therapeutic Vaccines Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

The global therapeutic vaccines market was valued at USD 11 billion in 2015 and is projected to reach USD 51 billion by 2021, at a CAGR of 29% during the forecast period. The increasing prevalence of chronic ...

Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021

  • $ 3500
  • Industry report
  • May 2017
  • by Infiniti Research Limited

About Anti-Nuclear Antibody (ANA) Testing Antibodies that attack healthy proteins in the nucleus cells are called antinuclear antibodies. When a person has an autoimmune disease such as rheumatoid arthritis ...


Download Unlimited Documents from Trusted Public Sources

Lymphoma Statistics in Germany

  • September 2017
    167 pages
  • Lymphoma  

    Cancer  

    Leukemia  

  • Germany  

    Europe  

    United States  

View report >

Cancer Statistics in the US - Forecast

  • September 2017
    3 pages
  • Hospital  

    Blood Disease  

  • United States  

    Europe  

View report >

Autoimmune Disease Statistics in the US

  • September 2017
    9 pages
  • Autoimmune Dise...  

    Hospital  

  • United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.